Clinical Laboratory Compliance Improvement Act of 2004

Summary

Clinical Laboratory Compliance Improvement Act of 2004 - Amends title XVIII (Medicare) of the Social Security Act to require each provider or clinical laboratory approved for participation under Medicare to provide clinical diagnostic laboratory tests to post in a conspicuous place a notice to employees that indicates the manner in which to report instances of noncompliance with conditions of participation. Prohibits such a provider or clinical laboratory from discriminating against or retaliating in any manner against any employee because that employee, or any other person, has presented a grievance or complaint, or has initiated or cooperated in any investigation or proceeding of any kind, relating to the clinical diagnostic laboratory tests performed or other requirements and prohibitions of Medicare. Provides for judicial action for any employee so aggrieved. Requires the investigative organization, upon receipt of a report of an instance of noncompliance, to: (1) provide notice to the Secretary and other investigative organizations involved of receipt of the report within three business days, using a standard format and manner of transmission developed by the Secretary for such purpose; (2) promptly determine whether to investigate the report; and (3) if appropriate, promptly investigate it. Requires that the Secretary, in measuring the performance of an investigative organization under contract, to provide for appropriate adjustments to payments for failure to carry out the responsibilities of this Act. Subjects each provider or clinical laboratory to a standard survey, including verification of compliance with requirements, conducted without prior notice. Makes liable for civil monetary penalties any individual who notifies (or causes to be notified) a provider or laboratory of the time or date on which such a survey is scheduled to be conducted.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

1. 8 October 2004

   Referred

   Referred to the Subcommittee on Health.

   Source: Committee

2. 8 October 2004

   Introduced

   Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

   Source: IntroReferral

3. 8 October 2004

   Introduced

   Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

   Source: IntroReferral

4. 8 October 2004

   Introduced

   Introduced in House

   Source: IntroReferral

5. 8 October 2004

   Introduced

   Introduced in House

   Source: IntroReferral

6. 11 October 2004

   Introduced

   Sponsor introductory remarks on measure. (CR E1944-1945)

   Source: IntroReferral

7. 25 October 2004

   Referred

   Referred to the Subcommittee on Health.

   Source: Committee

Votes

No vote records are attached yet.

Versions

• Introduced in House · 8 October 2004 · Official file

Documents

3 official files

• Introduced in House (text)

  Introduced in House · EN · 8 October 2004

  ViewDownloadOpen at official source

• Introduced in House (PDF)

  Introduced in House · EN · 8 October 2004

  ViewDownloadOpen at official source

• Introduced in House

  summary · EN · 8 October 2004

  Open at official source

Sponsors

• ELIJAH CUMMINGS · D · Sponsor
• · hswm00 · Standing
• · hsif00 · Standing

Related records

No cross-record relationships stored yet.